The spectrum of behaviors influenced by serotonin

被引:975
作者
Lucki, I
机构
[1] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
serotonin; behavior; feeding; aggression; neuroendocrinology; anxiety; depression;
D O I
10.1016/S0006-3223(98)00139-5
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
The diverse array of behavioral effects of serotonin form the basis for understanding its potential role as an etiological marker in psychiatric disorders and for the successful pharmacologic intervention of drugs regulating serotonin neurotransmission in behavior. General theories of the behavioral functions of serotonin have implicated serotonin as a general inhibitor of behavioral responding and in modulating motor behavior. The ability of serotonin to regulate behavioral satiety and macronutrient selection provides the basis for pharmacologic treatment of obesity and eating disorders. The role of serotonin in behavioral suppression may be important in social behavior involving aggression and anxiety. The role of serotonin in neuroendocrine regulation provides a basis for understanding serotonin dysregulation in depression. Animal behavior tests are being used to better understand the neural substrates underlying the behavioral effects of antidepressant drugs and to address important issues in clinical treatment. The integration of information between basic and clinical studies provides the basis for future development of more sophisticated pharmacologic treatments of psychiatric disorders. (C) 1998 Society of Biological Psychiatry.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 114 条
[1]
Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas [J].
Adell, A ;
Casanovas, JM ;
Artigas, F .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :735-741
[2]
[Anonymous], CRIMINAL BEHAV MENTA
[3]
SELECTIVE SEROTONIN NORADRENALINE REUPTAKE INHIBITORS (SNRIS) - PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF DEPRESSIVE-DISORDERS [J].
ARTIGAS, F .
CNS DRUGS, 1995, 4 (02) :79-89
[4]
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS LESIONS DIFFERENTIALLY AFFECT SEROTONIN-1A (5-HT1A) AND 5-HT2 RECEPTOR AGONIST-INDUCED OXYTOCIN, PROLACTIN, AND CORTICOSTERONE RESPONSES [J].
BAGDY, G ;
MAKARA, GB .
ENDOCRINOLOGY, 1994, 134 (03) :1127-1131
[5]
CIRCADIAN CORTICOSTERONE RHYTHM DID NOT DEVELOP IN RATS 7 WEEKS AFTER DESTRUCTION WITH 5,7-DIHYDROXYTRYPTAMINE OF THE SEROTONINERGIC NERVE-TERMINALS IN THE SUPRACHIASMATIC NUCLEUS AT THE AGE OF 16 DAYS [J].
BANKY, Z ;
HALASZ, B ;
NAGY, G .
BRAIN RESEARCH, 1986, 369 (1-2) :119-124
[6]
DO ANTIDEPRESSANTS STABILIZE MOOD THROUGH ACTIONS ON THE HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL SYSTEM [J].
BARDEN, N ;
REUL, JMHM ;
HOLSBOER, F .
TRENDS IN NEUROSCIENCES, 1995, 18 (01) :6-11
[7]
Barr R. S., 1993, ORSA Journal on Computing, V5, P2, DOI 10.1287/ijoc.5.1.2
[8]
Psychopharmacology of central serotonergic systems [J].
Baumgarten, HG ;
Grozdanovic, Z .
PHARMACOPSYCHIATRY, 1995, 28 :73-79
[9]
BIZOT JC, 1988, J PHARMACOL EXP THER, V246, P1144
[10]
ROLE OF THE SEROTONERGIC SYSTEM IN THE FORCED SWIMMING TEST [J].
BORSINI, F .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1995, 19 (03) :377-395